HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Landmark EU Ruling: Animal-Tested Cosmetic Ingredients Not Banned Per Se

This article was originally published in The Rose Sheet

Executive Summary

Firms cannot use safety data derived from third-country animal testing to substantiate product safety in accordance with the European Cosmetics Regulation, but such testing does not in itself constitute a violation of the EU’s animal-testing ban. It may be more challenging to compile required safety-assessment reports, but companies don’t necessarily have to choose between the EU and emerging markets such as China.

You may also be interested in...



US Humane Cosmetics Act Backed By Industry And NGOs Alike; Here’s Why

The proposed bill in the US Senate could be seen as slightly friendlier to the cosmetics industry when it comes to continued use of animal testing data in limited, exempted contexts, compared with similar state laws enacted of late. But the federal bill includes stiffer penalties, addresses “cruelty free” labeling, and seeks to spur FDA acceptance of alternative test methods, a key objective for stakeholders overall.

California’s Cruelty-Free Cosmetics Act Makes New Ingredients Officially Endangered

It’s debatable the extent to which SB 1249, now headed to the governor’s desk, will improve animals’ lot, but cosmetic ingredient innovation is almost certain to suffer. Industry could escalate efforts behind alternative methods development, or there’s another possible solution: federal preemption.

EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling

EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel